Gaslighting in Gastro Care; Antidepressants and IBS Mortality; Diverticulitis Season

Authors in Gastro Hep Advances reviewed medical gaslighting in gastroenterology, distinguishing the phenomenon from legitimate diagnostic uncertainty or persistent patient concern despite appropriate care.

The American Gastroenterological Association announced the launch of a professional development program to help gastroenterologists navigate how artificial intelligence and evolving care models are transforming the field.

Higher-than-standard doses of antibiotics or bismuth in quadruple regimens for Helicobacter pylori were not linked to better outcomes, European registry data showed. (Clinical Gastroenterology and Hepatology)

Long-term use of antidepressants and certain antidiarrheals were associated with a higher risk of early death among patients with irritable bowel syndrome (IBS), a large study of health records found. (Communications Medicine)

Research linked emulsifiers and artificial sweeteners to greater disease activity in Crohn’s disease. (Gut)

A retrospective study on mothers who developed Crohn’s in childhood offered reassurance on neonatal outcomes. (Gastro Hep Advances)

Can proactive therapeutic drug monitoring during anti-TNF maintenance therapy improve outcomes in pediatric inflammatory bowel disease? (Gastro Hep Advances)

JAMA reviewed the American College of Gastroenterology’s updated guidelines on managing adult Crohn’s disease.

Meanwhile, Clinical Gastroenterology and Hepatology published updated recommendations on the management of metabolic dysfunction-associated steatotic liver disease.

An investigational L-ornithine phenylacetate demonstrated short-term ammonia-lowering activity in a phase IIa trial of overt hepatic encephalopathy. (Hepatology)

Pradefovir mesylate, a liver-targeting prodrug of adefovir, proved noninferior to tenofovir disoproxil fumarate (Viread) for viral suppression in chronic hepatitis B, according to a phase III trial in China. (Hepatology)

A machine-based learning model showed accuracy in predicting Barrett’s esophagus recurrence and the timing of it following endoscopic eradication. (Clinical Gastroenterology and Hepatology)

Experts in JAMA Surgery discussed the ethics of liver transplantation for colorectal cancer patients with liver metastases.

Single-center data from France found a hepatitis E infection incidence of 3.5% in organ transplant recipients over the past two decades, with a rate of 5.4% in liver transplant patients. (Hepatology)

Incidence of diverticulitis more commonly peaks in warmer months, suggesting environmental or behavioral triggers, a global systematic review found. (JAMA Surgery)

Please enable JavaScript to view the comments powered by Disqus.